181 related articles for article (PubMed ID: 31075744)
1. Nimesulide analogues: From anti-inflammatory to antitumor agents.
Catarro M; Serrano JL; Ramos SS; Silvestre S; Almeida P
Bioorg Chem; 2019 Jul; 88():102966. PubMed ID: 31075744
[TBL] [Abstract][Full Text] [Related]
2. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
[TBL] [Abstract][Full Text] [Related]
3. The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?
Caiazzo E; Ialenti A; Cicala C
Eur J Pharmacol; 2019 Apr; 848():105-111. PubMed ID: 30689999
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a biotinylated probe of COX-2 inhibitor nimesulide analog JCC76.
Zhong B; Lama R; Smith KM; Xu Y; Su B
Bioorg Med Chem Lett; 2011 Sep; 21(18):5324-7. PubMed ID: 21807508
[TBL] [Abstract][Full Text] [Related]
5. Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells.
Su B; Chen S
Bioorg Med Chem Lett; 2009 Dec; 19(23):6733-5. PubMed ID: 19854050
[TBL] [Abstract][Full Text] [Related]
6. Developments in synthesis of the anti-inflammatory drug, celecoxib: a review.
Kumar V; Kaur K; Gupta GK; Gupta AK; Kumar S
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):124-34. PubMed ID: 23565678
[TBL] [Abstract][Full Text] [Related]
7. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI
Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709
[TBL] [Abstract][Full Text] [Related]
8. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of Nimesulide-Loaded Nanoparticles for Anticancer Activity Against Breast Cancer Cells.
Sengel-Turk CT; Hascicek C; Bakar F; Simsek E
AAPS PharmSciTech; 2017 Feb; 18(2):393-403. PubMed ID: 27007742
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
11. From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.
Zhong B; Cai X; Chennamaneni S; Yi X; Liu L; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
Eur J Med Chem; 2012 Jan; 47(1):432-444. PubMed ID: 22119125
[TBL] [Abstract][Full Text] [Related]
12. Methylene-bearing sulfur-containing cyanopyrimidine derivatives for treatment of cancer: Part-II.
Akhtar W; Nainwal LM; Kaushik SK; Akhtar M; Shaquiquzzaman M; Almalki F; Saifullah K; Marella A; Alam MM
Arch Pharm (Weinheim); 2020 May; 353(5):e1900333. PubMed ID: 32115728
[TBL] [Abstract][Full Text] [Related]
13. Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors.
Bechmann N; Kniess T; Köckerling M; Pigorsch A; Steinbach J; Pietzsch J
Bioorg Med Chem Lett; 2015 Aug; 25(16):3295-300. PubMed ID: 26081289
[TBL] [Abstract][Full Text] [Related]
14. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
[TBL] [Abstract][Full Text] [Related]
17. Coumarins scaffolds as COX inhibitors.
Revankar HM; Bukhari SN; Kumar GB; Qin HL
Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study.
Abdel-Aziz AA; El-Azab AS; AlSaif NA; Alanazi MM; El-Gendy MA; Obaidullah AJ; Alkahtani HM; Almehizia AA; Al-Suwaidan IA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):610-621. PubMed ID: 32013633
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
[TBL] [Abstract][Full Text] [Related]
20. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
Kumar R; Saha N; Purohit P; Garg SK; Seth K; Meena VS; Dubey S; Dave K; Goyal R; Sharma SS; Banerjee UC; Chakraborti AK
Eur J Med Chem; 2019 Nov; 182():111601. PubMed ID: 31445233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
